2021
COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects
RIAD, Abanoub, Holger SCHÜNEMANN, Sameh ATTIA, Tina POKLEPOVIĆ PERIČIĆ, Marija Franka ŽULJEVIĆ et. al.Základní údaje
Originální název
COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects
Autoři
RIAD, Abanoub (818 Egypt, garant, domácí), Holger SCHÜNEMANN, Sameh ATTIA, Tina POKLEPOVIĆ PERIČIĆ, Marija Franka ŽULJEVIĆ, Mikk JÜRISSON, Ruth KALDA, Katrin LANG, Sudhakar MORANKAR, Elias Ali YESUF, Mohamed MEKHEMAR, Anthony DANSO-APPIAH, Ahmad SOFI-MAHMUDI, Giordano PÉREZ-GAXIOLA, Arkadiusz DZIEDZIC, João APÓSTOLO, Daniela CARDOSO, Janja MARC, Mayte MORENO-CASBAS, Charles Shey WIYSONGE, Amir QASEEM, Anna GRYSCHEK, Ivana TADIĆ, Mohammad Salman HUSSAIN (356 Indie, domácí), Mohammed Ahmed KHAN, Jitka KLUGAROVÁ (203 Česká republika, domácí), Andrea POKORNÁ (203 Česká republika, domácí), Michal KOŠČÍK (203 Česká republika, domácí) a Miloslav KLUGAR (203 Česká republika, domácí)
Vydání
International Journal of Environmental Research and Public Health, Basel, MDPI, 2021, 1660-4601
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30304 Public and environmental health
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.614
Kód RIV
RIV/00216224:14110/21:00122061
Organizační jednotka
Lékařská fakulta
UT WoS
000681945000001
Klíčová slova anglicky
cohort studies; cross-sectional studies; COVID-19; drug-related side effects and adverse reactions; health personnel; mass vaccination; prevalence
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 12. 12. 2022 13:40, Mgr. Tereza Miškechová
Anotace
V originále
Background: Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses’ side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.
Návaznosti
MUNI/A/1608/2020, interní kód MU |
| ||
MUNI/IGA/1543/2020, interní kód MU |
|